Taking the first steps

It is customary to wait at least until a company approaches adolescence before venturing any sort of opinion on its prospects. Go Life remains in the mewling and puking stage, taking its first steps with its posterior protected by Pampers’ finest. But in a thin news week, with the final remnants of festive goodwill still flowing around the system, we must take what we can.

The Altx has not exactly had a stellar track record as a nursery of champions, generally acting as a mere staging post along the boulevard of broken dreams. The theory of allowing relaxed listing criteria to open up a school of minnows to raise capital under the merciless glare of public scrutiny makes sense. But the exchange has attracted more than its share of garbage, to the extent that anything that looks like it has a vaguely sane business plan stands out.

Go Life kicked off with the intention of supplying the nutraceutical market, beloved of the neckless bodybuilder and the more credulous civilian alike. Its claims to have natural products scientifically developed in the womb of Africa and enhanced through unique technology could cause anybody with a mildly sensitive bullshit meter to set off all the alarms at once, but it has subsequently tweaked its ambitions towards becoming a fully fledged medical and health-care services company.

It has bought into Bon Health, which operates frail care and retirement villages including Alzheimer’s and dementia facilities, which is right in the sweet spot for an ageing population. It has a way to go to challenge the majors, but it’s a start.

Go Life has tweaked its ambitions towards becoming a fully fledged medical and health-care services company